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Red-dot card test of the paracentral field
as a screening test for optic nerve disease
in onchocerciasis*
1. Murdoch,1,2 B.R. Jones,1,2 O.E. Babalola,1 S.N. Cousens,3 I. Bolarin,1 &
A. Abiose1 4
A new screening test for optic nerve pathology is described, consisting of a series of four red targets
presented at an angle of 120 in the paracentral field above and below the horizontal meridian. Non-
perception and desaturation of the targets are recorded. Inter-observer variability studies found a K value =
0.8. A total of 6831 individuals aged -5 years in communities that were mesoendemic for savanna
onchocerciasis in Kaduna State, northern Nigeria, were screened using the test. Of the participants 22%
were unable to complete the test; almost two-thirds of these (62%) were aged 5-8 years. After exclusion of
those visually impaired or blind according to WHO criteria and those unable to complete the test, the test
showed a sensitivity of 40% and a specificity of 98% for optic nerve disease when inability to visualize one
or more targets was used as the definition of test failure. The sensitivity increased to 54% with a specificity
of 96% when the criterion for failure included desaturation of one or more targets. These values compare
favourably with those for other available screening methods. The test took 1-2 minutes to perform and was
readily accepted by patients and nurses.
Introduction
Traquair postulated that all colour isopters were of
equal size if hue, saturation and intensity were
equated (1), and this has been corroborated by sub-
sequent work by Carlow et al. (2). The presence of
central and/or paracentral red desaturation, how-
ever, remains a useful indicator of significant optic
nerve damage (3, 4).
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In a large community-based trial of ivermectin
for the treatment of onchocerciasis in the guinea
savanna of Kaduna State, northern Nigeria, commu-
nities were screened for optic nerve disease to ascer-
tain whether ivermectin provoked optic neuritis with
loss of vision in the first few weeks after dosing, and
whether the drug given annually would exacerbate
or prevent onchocercal optic nerve disease from oc-
curring subsequently. A simple card test involving
presentation of red targets at an angle of 120 in the
paracentral field was devised for this purpose. This
article describes the test and presents an evaluation
of its use in screening.
Method and subjects
The red-dot card test is designed for use at 33cm
from the patient's eyes and a cord of this length is
attached to the base of the card to ensure easy deter-
mination of this working distance. The card itself
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consists of a central fixation hole and four 1-cm di-
ameter circular areas which lie above and below the
horizontal meridian at an angle of 120 from fixation.
These circular areas can be turned red by moving the
"slides" at the side of the test card. In addition there
are four "dummy holes" in the card so the patient
does not know where the red colour will appear. A
central hole for the examiner's eye ensures that cen-
tral fixation can be checked throughout the test. The
cards were manufactured locally and laminated for
durability in the field (Fig. 1).
The test identifies two levels of defect: (1) when
all spots are seen but one or more spot is reported as
having colour desaturation; and (2) when one or
more red spots are not seen.
Six ophthalmic nurses were trained in the use of
the cards and a small inter-observer study was car-
ried out. The nurses worked in pairs in the local
ophthalmic outpatient department, each pair testing
41 patients (82 eyes) with the card; each patient was
tested separately by both nurses. For the 82 eyes
tested there were five discordant results: for two eyes
one nurse recorded inability to see one spot and
another nurse recorded ability to see it; in one eye
desaturation was recorded by one nurse and not by
the other; and in the final two eyes there was dis-
agreement as to which quadrant/hemifield showed
desaturation (overall K = 0.8).
A total of 6831 individuals aged -5 years were
screened for optic nerve disease using a variety of
screening tools including visual acuity, blue-yellow
colour perception, Arden contrast sensitivity grat-
ings, paracentral confrontation with a 6-mm white
target, and peripheral confrontation by counting
fingers in four outer quadrants, in addition to ocular
Fig. 1. Use of the red-dot card test on the left eye of an
individual. The slides are both withdrawn, so no red dots
are currently visible. The observer is holding the card test
and checking the patient's fixation by looking through the
central hole.
examination with fundoscopy (5). Mark-1 Fried-
mann field analysis was performed on a random
sample (n = 329) of those screened and on all those
in whom optic nerve pathology was suspected from
any of the above tests. If three or more spots were
missed or four or more spots had reduced sensitivity
in any quadrant with the Friedmann test, a field
defect was considered to be present.
In all instances the free and informed consent of
the subjects was obtained prior to testing.
On the basis of the findings in the random sam-
ple, the full screening process ("gold standard") was
shown to have >99% sensitivity for detecting optic
nerve disease. Individuals identified as having pos-
sible optic nerve disease were given a detailed ex-
amination by ophthalmologists, which included the
Friedman field test, dilated fundoscopy for optic disc
assessment, and fluorescein angiography to look for
optic neuritis. A diagnosis of definite or probable
optic nerve disease was then made according to the
criteria shown below.
* Definite optic nerve disease
marked disc pallor recorded by an ophthalmolo-
gist together with defects in visual function and/
or pupillary light response; or
active optic neuritis confirmed by fluorescein
angioscopy and angiography
* Probable optic nerve disease
an eye with no perception of light together with
no view of the disc and no history or other ocular
pathology to account for the finding; or
an afferent pupillary defect identified by an oph-
thalmologist together with no view of the disc
and no history or other ocular pathology to ac-
count for the finding; or
mild or moderate disc pallor recorded by an oph-
thalmologist in association with recorded defects
in visual function or an afferent pupillary defect;
or
Table 1: Comparison of the results of the red-dot card
assessment of visual fields by ophthalmic nurses with
those of the Friedmann field test (results for single
eyes)a
Ophthalmic nurse finding:
Friedmann field Red desaturation Red dot
test finding: Normal defect not seen
Normal 867 118 33
Defect 319 89 321
a K for desaturation or not seen = 0.43; K for not seen = 0.44.
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Table 2: Red-dot card assessment of optic nerve disease compared with a gold standard comprising a full
screening process plus an ophthalmological examination (results for single eyes after exclusion of individuals visually
impaired or blind according to WHO criteria)
Red-dot card test finding:
Gold standard Normal Red desaturation Red dot not seen Unable to perform test
No optic nerve disease 9340 234 198 2521
Probable or definite optic nerve disease 262 76 227 142
disc pallor recorded by an ophthalmic nurse, disc
not seen by an ophthalmologist and three or
more visual function tests failed or an afferent
pupillary defect.
Results
The results obtained using the red-dot card test and
those using the Friedmann field test are compared in
Table 1. A comparison of performance in the red-dot
card test with that in the gold standard is shown in
Table 2. Individuals who were visually impaired or
blind according to WHO criteria have been excluded
from the analysis.
For detection of optic nerve disease, the sensi-
tivity of the red-dot card test was 32% for inability to
see one or more dots (40% after exclusion of those
unable to perform the test) and 43% for inability to
see a dot or perceive desaturation of a spot (54%
after exclusion of those unable to perform the test).
The specificity was 78% for inability to see one or
more dots (98% after exclusion of those unable to
perform the test) and 76% for inability to see a dot
or perception of desaturation (96% after exclusion
of those unable to perform the test).
Inability to perform the test was strongly linked
to age, with 62% of all those unable to perform
the test being aged 5-8 years. The sensitivity and
specificity levels are quoted here with exclusion of
those unable to perform the test.
Discussion
The sensitivity and specificity of the red-dot card test
compare favourably with those reported by Trobe et
al. for two colour tests carried out on 28 eyes with
chiasmal hemianopias, 17 eyes with optic nerve fibre
bundle defects, and 14 normal controls. Using a
confrontation technique and a tangent screen tech-
nique, they reported a sensitivity of 79-83% for
chiasmal defects and only 17-34% for optic nerve
defects using static targets. The specificities were 73-
74% for chiasmal defects and 100% for optic nerve
defects.
The time taken is always an important consid-
eration in undertaking screening work. The red-dot
card test took 1-2 minutes per subject to explain and
perform, a similar time to the simultaneous counting
fingers field test and slightly longer than visual acuity
testing. An average of 15 minutes was taken for a
Friedmann field examination. The red-dot card
test proved acceptable to patients and staff in field
work aimed at screening populations for optic nerve
disease.
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Resume
Un nouveau test de depistage de l'atteinte
du nerf optique dans l'onchocercose: le
Red Dot Card Test
Cet article decrit un nouveau test de d6pistage de
I'atteinte du nerf optique (Red Dot Card Test), qui
consiste a pr6senter un carton portant quatre points
rouges a un angle de 12° dans le champ paracen-
tral, au-dessus et au-dessous du meridien horizon-
tal. L'absence de perception et la d6saturation des
points rouges sont not6es. L'6tude de la variabilite
inter-observateurs chez des infirmiers en ophtalmo-
logie effectuant le test a montre des r6sultats dis-
cordants pour cinq des 82 yeux examin6s (K = 0,8).
Au total, 6831 personnes agees de cinq ans
et plus, vivant dans des communautes ou l'oncho-
cercose de savane est m6soend6mique, ont 6t6
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examin6es dans l'Etat de Kaduna, dans le nord du
Nig6ria. Parmi les sujets examines, 22% ont 6te in-
capables de faire le test; pres des deux tiers d'entre
eux (62%) etaient des enfants de cinq a huit ans.
Les r6sultats ont et6 compares a ceux d'une
m6thode de d6pistage beaucoup plus complete
des l6sions patentes ou probables du nerf optique,
de sensibilit6 sup6rieure a 99% et prise comme
reference. Apres exclusion des sujets atteints
d'une perte de vision ou aveugles selon les criteres
de l'OMS, et des malades incapables de faire le
test, on a obtenu une sensibilite de 40% et une
sp6cificit6 de 98% pour le d6pistage d'une atteinte
du nerf optique en prenant comme d6finition de test
n6gatif l'incapacit6 de voir au moins un des quatre
points. La sensibilit6 passait a 54% avec une
sp6cificit6 de 96% lorsque le critere de n6gativit6
prenait en compte la d6saturation d'un ou plusieurs
points. Ces resultats sont tout a fait comparables a
ceux des autres m6thodes de d6pistage disponi-
bles. Le test s'ex6cute en une a deux minutes et est
bien accept6 par les malades et par les infirmiers.
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